Navigation Links
Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
Date:2/17/2010

live call and will be available for a period of two weeks.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You can identify these statements by the fact that they use words such as "anticipate," "believe," "estimate," "expect," "intend," "project," "plan," "outlook," and other words and terms of similar meaning. These statements involve a number of risks and uncertainties that could cause actual results to differ materially from the potential results discussed in the forward-looking statements. Among the factors that could cause actual results and outcomes to differ materially from those contained in such forward-looking statements are the following: our ability to access sufficient working capital, including a new working capital line; our continued compliance with the representations, warranties and covenants under our existing convertible debenture; our continued history of losses, which includes net losses in three of the last five fiscal years; the timing and size of customer orders for our products; the adoption, timing and performance of new technology and products developed by us; changes and advances in technology that may make our products obsolete or reduce demand for our products; our ability to protect and maintain the confidentiality of our Intellectual property; our ability to retain key employees and our reliance on a new management team; changes in governmental rules and regulations, including those regulating the exportation of goods; and general economic and business conditions and the financial crisis, including those adversely effecting the pharmaceutical and biotechnology industries. For a more detailed discussion of risks and uncertainties which could cause actual results to d
'/>"/>

SOURCE Microfluidics International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Microfluidics Enters into Exclusive Partnership with ATS Scientific to Expand Distribution in Canada
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
5. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
8. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 03, 2015 Research ... addition of the "Investigation Report on China,s ... The clinical demand for steroid drug ... and good efficacy especially its extended use in ... recent years. Progesterone, a natural progestogen produced ...
(Date:9/3/2015)... , Sep. 03, 2015 ... of the "Investigation Report on China,s Trastuzumab Market, ... by Genentech, trastuzumab was approved by FDA to be ... trade name of Herceptin, a major product of Roche. ... 6.56 billion around the world. After entering ...
(Date:9/3/2015)... 2015  Abaxis, Inc. (NasdaqGS: ABAX ), a ... to the medical, research and veterinary markets, announced today ... present at the CL King 13 th Annual ... at 11:00 a.m. ET. The conference will be held ... New York City . Abaxis, Inc. ...
Breaking Medicine Technology:China Progesterone Market Investigation Report 2015-2019 2Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2
... CVS ) today announced that Troyen A. Brennan, MD, ... company, has been named to the National Commission ... will assess how physicians are paid, and how pay incentives ... )   The commission is sponsored by the ...
... 5, 2012  CVS/pharmacy is informing pharmacy customers about the ... their prescriptions to help them on their path to ... policy research with Harvard University and Brigham and Women,s ... healthy and save money. For example, patients who use ...
Cached Medicine Technology:CVS Caremark's Chief Medical Officer Troyen Brennan is Named to the National Commission on Physician Payment Reform 2CVS/pharmacy Helping People on Their Path to Better Health Through Improved Medication Adherence 2
(Date:9/3/2015)... ... September 03, 2015 , ... Girl’s Night Out to ... beautiful Morning Glory Farm, 6205 Kate Road in Monroe, North Carolina. The ... a corporate or social function, Kate Clyde’s offers off-premise catering and event services from ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... comprehensive eating disorder treatment for adults and adolescents struggling with anorexia, bulimia, ... has joined the medical treatment team. As a Staff Psychiatrist, Dr. Calinoiu ...
(Date:9/3/2015)... ... September 03, 2015 , ... According to an ... convenient test that may help patients with oropharyngeal cancer (oral cancer) to be successfully ... States are often caused by HPV infections, which have a high rate of success ...
(Date:9/3/2015)... ... September 03, 2015 , ... Atlantic Information Services, Inc. ... Pharmacy Benefit Strategies for a Rapidly Changing Marketplace.” In this Sept. 16 program, ... will discuss how plan sponsors are adopting bold, innovative strategies to control soaring ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... endpoint data collection, cloud analytics and workflow solutions today announced the complete ... Portugal, September 22-24, 2015. The esteemed faculty of worldwide pharmaceutical and industry ...
Breaking Medicine News(10 mins):Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 2Health News:Ileana Calinoiu, MD Joins Eating Recovery Center of Washington Medical Treatment Team 3Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 2Health News:LA Periodontists Discuss Study on Post-Treatment Oral Rinses Used to Test Recurrence of Oral Cancers 3Health News:Speakers for Upcoming AIS Virtual Conference on Pharmacy Benefit Strategies Include Executives from CVS Health, Express Scripts 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3
... ... Studies offers Professional Certificates in Project Management both online and in the classroom starting ... , ... 19, 2009 -- San Diego State University,s College of Extended Studies will offer spring ...
... ... operational efficiencies. , ... Charlotte, NC (Vocus) November 19, 2009 -- Morehead, the human capital research firm, will ... webinar will be broadcast on Thursday, December 10, 2009 at 1:00 p.m. EST. ...
... , STAMFORD, Conn., Nov. 18 AmeriCares and ... the Philippines, where thousands of people are still reeling from ... Floodwaters from Typhoon Ketsana and other storms have been slow ... tens of thousands still homeless and living in crowded evacuation ...
... , KING OF PRUSSIA, Pa., Nov. 18 ... that its Board of Directors has declared a two for one ... on December 15, 2009 to shareholders of record as of December ... pro rata basis. The Board,s decision should improve liquidity and trading ...
... N.J., Nov. 18 GettingHired, LLC , ... disabilities, announced today that it has secured $3 million of ... disability employment portal in the USA as well as final ... work initiative supporting the long term disability and workers, compensation ...
... , WASHINGTON, Nov. 18 The ... TIME Magazine Foreign Correspondent Vivienne Walt with its ... meeting. , "Ms. Walt,s work has unveiled the need ... to improve healthcare around the world," said Thomas Wellems, MD, ...
Cached Medicine News:Health News:San Diego State Offers Project Management Programs Beginning in January 2Health News:Morehead Presents Webinar on "How Physician Attitudes Impact Hospital Goals " 2Health News:AmeriCares and Boeing Deliver Emergency Relief Supplies to the Philippines 2Health News:GettingHired Announces Additional Funding for Continued Growth as Well as R&D of New Product for Long Term Disability and Workers' Comp. 2Health News:GettingHired Announces Additional Funding for Continued Growth as Well as R&D of New Product for Long Term Disability and Workers' Comp. 3Health News:Acclaimed American Journalist Awarded Excellence In Journalism by American Society of Tropical Medicine and Hygiene 2
Ruschelit® PVC. Murphy eye-nasoral. X-ray opaque line. Graduated. Single use. Sterile...
Ruschelit® PVC. Magill tip - nasoral. X-ray opaque line. Graduated. Single use. Sterile...
... Set® Tube with stylet inside. Sterile, ... uncuffed Rusch endotracheal tube with a ... use saving you time and storage ... for easy identification and has a ...
... PVC. Murphy eye-nasal. High volume/low pressure ... For improved surgical access. Designed to ... incorporating a preformed curvature. Thin-walled, large ... adapts to the anatomical situation at ...
Medicine Products: